Page last updated: 2024-09-04

moxifloxacin and ajm300

moxifloxacin has been researched along with ajm300 in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (ajm300)	Trials (ajm300)	Recent Studies (post-2010) (ajm300)
3,157	552	1,690	11	4	11

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Goto, A; Ikeda, N; Izumi-Nakaseko, H; Kambayashi, R; Kumagai, Y; Matsuda, K; Matsumoto, A; Oikawa, I; Sugiyama, A; Takei, Y	1

Trials

1 trial(s) available for moxifloxacin and ajm300

Article	Year
Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects. Journal of pharmacological sciences, 2022, Volume: 150, Issue:3 Topics: Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Integrin alpha4; Japan; Long QT Syndrome; Moxifloxacin; Phenylalanine; Quinazolinones	2022

Article

Year

Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects.

Journal of pharmacological sciences, 2022, Volume: 150, Issue:3

Topics: Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Integrin alpha4; Japan; Long QT Syndrome; Moxifloxacin; Phenylalanine; Quinazolinones

2022